-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD), the most common form of dementia, is neuropathologically defined as the accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles
Then, around age 50, tau appears in the brain cortex, followed by Aβ and tau accumulation in the neocortex around age 60
In older adults, including preclinical sporadic AD, with specialized magnetic resonance imaging (MRI) methods, LC integrity peaks and begins to decline at age 54, which is the time in life when cortical tau begins to appear
Individuals carrying mutations in presenilin-1 (PSEN1) are destined to develop autosomal dominant Alzheimer's disease (ADAD) in early adulthood
In ADAD, Aβ deposition predates cortical tau pathology by ≈10 to 15 years
Given that LC is the initial site of pre-entangled matter in AD, tau is closely related to cognition
With this, Heidi IL Jacobs et al.
They used MRI to correlate LC integrity with PET and recognition of Aβ and Tau in the largest known ancestry of PSEN1 E280A (Glu280Ala) mutation carriers and age-matched non-carrier family members living in Antioquia, Colombia.
A subset of these carriers also had follow-up imaging and cognitive data after an average of 2 years, enabling the assessment of whether LC integrity was consistent with changes in tau and to determine whether LC integrity might be useful in the search for early prognostic markers Hope
What they found: LC integrity in carriers began to decline at age 32 years, 12 years earlier than clinical onset, and 20 years earlier than sporadic AD
LC integrity in carriers begins to decline at age 32 years, 12 years before clinical onset and 20 years before sporadic AD
In addition, LC integrity was positively correlated with memory
These findings support LC integrity as a marker of preclinical ADAD disease progression
These findings support LC integrity as a marker of preclinical ADAD disease progression
Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.
Leave a comment here